In a big boost to India's fight against coronavirus, an expert panel of the central drug authority today cleared Covaxin and Covishield for full use, a year after the two vaccines were given emergency approval. The significant move is set to make the vaccines available more easily at clinics and hospitals registered with the government portal CoWIN.
This comes as the government deliberates over the booster dose policy.
SEC of CDSCO has recommended for upgrade of covishield and covaxin status from restricted use in emergency situations to grant of new drug permission with conditions In adult population ,DCGI will evaluate the recommendations and give its decision.
— CDSCO_INDIA_INFO (@CDSCO_INDIA_INF) January 19, 2022
The recommendations by the expert panel of the Central Drugs Standard Control Organisation have been sent to the top drug regulator DGCI. "SEC of CDSCO has recommended for upgrade of covishield and covaxin status from restricted use in emergency situations to grant of new drug permission with conditions In adult population ,DCGI will evaluate the recommendations and give its decision," the regulatory body tweeted.
